共 50 条
- [31] Discussing disease progression and end-of-life decisions - The Baile et al article reviewed ONCOLOGY-NEW YORK, 1999, 13 (07): : 1031 - 1032
- [32] Preventing Prostate Cancer Overdiagnosis From Becoming Overtreatment THE CROSWELL ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (06): : 468 - 478
- [33] The moving target of cancer care costs - The McKoy/Fitzner/Edwards et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 862 - +
- [34] Erlotinib in pancreatic cancer: A major breakthrough? The Senderowicz/Johnson/Sridhara et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (14): : 1706 - +
- [35] A new era in the management of multiple myeloma - The Ghobrial/Ghobrial/Mitsiades et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 800 - 800
- [36] Hepatocellular carcinoma: Neoadjuvant therapy reconsidered - The Almhanna/Kalmadi/Pelley et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1122 - +
- [37] Key developments in rectal cancer treatment - The Willet/Duda/Czito et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1075 - +
- [38] The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (04): : 430 - +
- [39] Follicular lymphoma: Expanding therapeutic options - The Ganti/Bociek/Bierman et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (02): : 234 - 235
- [40] On the Road to Intraoperative Radiotherapy: More 'Proceed With Caution' Signs THE ASH ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 113 - +